Albert Einstein College of Medicine in New York City has received a five-year, $4 million grant from the National Institutes of Health (NIH) to back the New York Regional Center for Diabetes Translation Research (NY-CDTR).
The NY-CDTR encourages collaboration and research on strategies designed to improve diabetes prevention, care, and self-management, with a focus on health equity.
“Our center is in a unique position, both geographically and due to our expertise—to support investigators who are conducting research aimed at helping those who shoulder the greatest burden of diabetes in the U.S.—namely people of color and those with lower socio-economic status,” said Jeffrey Gonzalez, PhD, principal investigator on the grant and director of the NY-CDTR, in a press release. “We will prioritize studies aimed at reducing health inequities and developing interventions that can be implemented under real world conditions and in diverse healthcare and community locations.”
This new funding is expected to go toward the center’s operations, including behavioral science and technology cores that are studying how telehealth, smartphone apps, continuous glucose monitoring devices and other technologies can be used to manage diabetes.